"10.1371_journal.pone.0080629","plos one","2013-12-12T00:00:00Z","Christopher D Pilcher; Brian Louie; Shelley Facente; Sheila Keating; John Hackett; Ana Vallari; Chris Hall; Teri Dowling; Michael P Busch; Jeffrey D Klausner; Frederick M Hecht; Sally Liska; Mark W Pandori","HIV/AIDS Division, University of California San Francisco, San Francisco, California, United States of America; Public Health Laboratory, San Francisco Department of Public Health, San Francisco, California, United States of America; HIV Prevention Section, San Francisco Department of Public Health, San Francisco, California, United States of America; STD Prevention and Control Services Section, San Francisco Department of Public Health, San Francisco, California, United States of America; Blood Systems Research Institute, San Francisco, California, United States of America; Abbott Diagnostics, Abbott Park, Illinois, United States of America; Magnet Community Health Center, San Francisco, California, United States of America","Conceived and designed the experiments: CDP BL JDK. Performed the experiments: JDK FMH CDP BL MWP SL AV JH MPB SK TD CH. Analyzed the data: CDP SF BL MWP. Contributed reagents/materials/analysis tools: JH. Wrote the paper: CDP BL SF SK MWP JH AV CH TD MPB SL JDK FMH.","The authors have read the journals policy and have the following conflicts: Drs. Hackett and Vallari are employed by Abbott Diagnostics, which markets the ARCHITECT HIV 1/2 test, one of the several HIV assays evaluated in this study. This does not alter the authors adherence to all the PLOS ONE policies on sharing data and materials.","2013","12","Christopher D Pilcher","CDP",13,TRUE,3,12,4,13,TRUE,TRUE,FALSE,0,NA,FALSE
